155 related articles for article (PubMed ID: 2410287)
1. Carbon monoxide diffusing capacity: a reliable indicator of bleomycin-induced pulmonary toxicity.
Sørensen PG; Rossing N; Rørth M
Eur J Respir Dis; 1985 May; 66(5):333-40. PubMed ID: 2410287
[TBL] [Abstract][Full Text] [Related]
2. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients.
Comis RL; Kuppinger MS; Ginsberg SJ; Crooke ST; Gilbert R; Auchincloss JH; Prestayko AW
Cancer Res; 1979 Dec; 39(12):5076-80. PubMed ID: 91430
[TBL] [Abstract][Full Text] [Related]
3. Late pulmonary toxicity after treatment for Hodgkin's disease.
Villani F; De Maria P; Bonfante V; Viviani S; Laffranchi A; Dell'oca I; Dirusso A; Zanini M
Anticancer Res; 1997; 17(6D):4739-42. PubMed ID: 9494599
[TBL] [Abstract][Full Text] [Related]
4. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
Kharasch VS; Lipsitz S; Santis W; Hallowell JA; Goorin A
Med Pediatr Oncol; 1996 Aug; 27(2):85-91. PubMed ID: 8649325
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
[TBL] [Abstract][Full Text] [Related]
6. [Role of single-breath carbon monoxide-diffusing capacity in monitoring the bleomycin-induced lung toxicity in human].
Wang JL; Ma SQ; Zhang YJ; Han JN; Zhu YJ; Ma Y; Shen K; Li LY
Zhonghua Nei Ke Za Zhi; 2003 Oct; 42(10):709-12. PubMed ID: 14633466
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary function in children treated for rhabdomyosarcoma.
Kaplan E; Sklar C; Wilmott R; Michaels S; Ghavimi F
Med Pediatr Oncol; 1996 Aug; 27(2):79-84. PubMed ID: 8649324
[TBL] [Abstract][Full Text] [Related]
8. The effect of tiotropium on the pulmonary diffusing capacity.
Gonlugur U
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):535-7. PubMed ID: 18040529
[TBL] [Abstract][Full Text] [Related]
9. [Bleomycin and pulmonary function changes in children with malignant lymphomas].
Kuijten RR; Voûte PA; van Nierop JC; van Leeuwen EF; Griffioen RW; Wagner-Soeters RE
Ned Tijdschr Geneeskd; 1991 Feb; 135(6):225-8. PubMed ID: 1706483
[TBL] [Abstract][Full Text] [Related]
10. Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).
Vriesendorp R; Aalders JG; Sleijfer DT; Willemse PH; Bouma J; Mulder NH
Cancer Treat Rep; 1984 May; 68(5):779-81. PubMed ID: 6202407
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary function assessment during bleomycin therapy.
Lampert-Benignus E; Eichler-Reiss F; Meunier-Carius J; Keiling R
Biomed Pharmacother; 1985; 39(2):87-93. PubMed ID: 2410052
[TBL] [Abstract][Full Text] [Related]
12. The effects of antireflux therapy on pulmonary function in patients with severe gastroesophageal reflux disease. Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group.
Spechler SJ; Gordon DW; Cohen J; Williford WO; Krol W
Am J Gastroenterol; 1995 Jun; 90(6):915-8. PubMed ID: 7771420
[TBL] [Abstract][Full Text] [Related]
13. The effect of corticosteroid administration on bleomycin lung toxicity.
Jensen JL; Goel R; Venner PM
Cancer; 1990 Mar; 65(6):1291-7. PubMed ID: 1689606
[TBL] [Abstract][Full Text] [Related]
14. The effect of pulmonary function testing on bleomycin dosing in germ cell tumours.
Roncolato FT; Chatfield M; Houghton B; Toner G; Stockler M; Thomson D; Friedlander M; Gurney H; Rosenthal M; Grimison P;
Intern Med J; 2016 Aug; 46(8):893-8. PubMed ID: 27305276
[TBL] [Abstract][Full Text] [Related]
15. Enhanced pulmonary toxicity in smokers with germ-cell cancer treated with cis-platinum, vinblastine and bleomycin: a long-term follow-up.
Hansen SW; Groth S; Sørensen PG; Rossing N; Rørth M
Eur J Cancer Clin Oncol; 1989 Apr; 25(4):733-6. PubMed ID: 2469589
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin-induced changes in the carbon monoxide transfer factor of the lungs and its components.
Luursema PB; Star-Kroesen MA; van der Mark TW; Sleyfer DT; Koops HS; Peset R
Am Rev Respir Dis; 1983 Nov; 128(5):880-3. PubMed ID: 6195947
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary function abnormalities in thalassemia patients on a hypertransfusion program.
Keens TG; O'Neal MH; Ortega JA; Hyman CB; Platzker AC
Pediatrics; 1980 May; 65(5):1013-7. PubMed ID: 7367114
[TBL] [Abstract][Full Text] [Related]
18. [Changes in pulmonary function in SARS patients during the three-year convalescent period].
Liu YX; Ye YP; Zhang P; Chen J; Ye H; He YH; Li N
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):536-8. PubMed ID: 17767822
[TBL] [Abstract][Full Text] [Related]
19. Melatonin administration acutely decreases the diffusing capacity of carbon monoxide in human lungs.
Vardar SA; Altun GD; Günerbuyuk C; Hatipoglu ON; Mert S; Kaymak K
Respiration; 2006; 73(4):509-13. PubMed ID: 16195665
[TBL] [Abstract][Full Text] [Related]
20. [Advanced germinal tumors of the testicle: clinical experience with cisplatin, bleomycin and vinblastine (PVB) or etoposide (BEP)].
Alonso Curbera G; González-Manzano R; Aramendía Beitia JM; Martínez Monge R; Agüera Fernández L; Rebollo Liceaga J
Rev Med Univ Navarra; 1993; 38(1):13-8. PubMed ID: 8711305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]